We provide broad experience in different indications with various study designs and processing including RDE (Remote Data Entry) and monitoring at ICUs e. g.:

 
• More than 160 site visits in the oncological indication.
• More than 100 site visits in the immunological indication.
• Close to 50 visits in the cardiovascular indication.

All activities are carried out according to the national and international laws and guidelines (AMG (G), WMO (NL), GCP/ICH, and/or FDA, CFR) and in accordance to the Standard Operating Procedures of the client.

 
The results of more than 20 Audits were good to excellent!